L-carnitine is a naturally occurring, vitamin-like compound synthesized from the amino acids lysine and methionine and also obtained from the diet, mainly red meat. Its central physiological role is to shuttle long-chain fatty acids across the inner mitochondrial membrane so they can undergo beta-oxidation, the process that supplies most of the heart's energy. Myocardial carnitine is depleted during ischemia and acute myocardial infarction, which impairs fatty-acid metabolism and has been linked to the accumulation of toxic intermediates and ventricular arrhythmias.
Older and mostly small randomized trials, pooled in meta-analyses, suggest that L-carnitine given around the time of an acute myocardial infarction is associated with reduced all-cause mortality, ventricular arrhythmias and angina, and with attenuated left-ventricular dilation and smaller infarct size, effects attributed to improved cardiac energy metabolism; however, dosing analyses show no clear benefit above roughly 3 g/day and large modern outcome trials are lacking. Outside the heart, a small trial in centenarians found less physical and mental fatigue, more muscle mass and better cognition with 2 g/day, and meta-analyses report modest weight loss (about 1 kg) and improved glycemic markers in type 2 diabetes. Importantly, dietary L-carnitine can be converted by gut bacteria to trimethylamine-N-oxide (TMAO), a metabolite whose higher blood levels are associated with increased cardiovascular events, a genuine and unresolved safety consideration for long-term daily use. The strongest evidence is in clinical and deficiency contexts; a general anti-aging benefit is unproven. This evidence concerns L-carnitine and its metabolism in general, not this specific commercial product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“L-carnitine has been associated with a significant reduction in all-cause mortality”
“L-carnitine was associated with a significant 27% reduction in all-cause mortality”
“L-carnitine is associated with a 27% reduction in all-cause mortality, a 65% reduction in ventricular arrhythmias, and a 40% reduction in anginal symptoms in patients experiencing acute myocardial infarction”
“In patients with OA, l-carnitine effectively decreases clinical signs and symptoms, inflammatory markers, pain, and stiffness indicators, and significantly improves WOMAC and VAS scores.”
“A significant attenuation of left ventricular dilation in the first year after acute myocardial infarction was observed in patients treated with L-carnitine compared with those receiving placebo.”
“At the end of the 28-day treatment period, the mean infarct size assessed by cardiac enzymes showed a significant reduction in the carnitine group compared to placebo.”
Research describes the active mechanism and is not a claim about this specific product.
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
Across meta-analyses and randomized trials, creatine monohydrate combined with…
In humans, randomized trials and meta-analyses most consistently show that astaxanthin…
Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…
Yes — its active compound is linked to 20 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.